- Home
- HLLY vs ABEO Comparison
HLLY vs ABEO Comparison
Compare HLLY & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLLY
- ABEO
- Stock Information
- Founded
- HLLY 1903
- ABEO 1974
- Country
- HLLY United States
- ABEO United States
- Employees
- HLLY N/A
- ABEO N/A
- Industry
- HLLY Auto Parts:O.E.M.
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- HLLY Consumer Discretionary
- ABEO Health Care
- Exchange
- HLLY Nasdaq
- ABEO Nasdaq
- Market Cap
- HLLY 322.9M
- ABEO 332.0M
- IPO Year
- HLLY N/A
- ABEO 1980
- Fundamental
- Price
- HLLY $3.57
- ABEO $7.13
- Analyst Decision
- HLLY Strong Buy
- ABEO Strong Buy
- Analyst Count
- HLLY 6
- ABEO 6
- Target Price
- HLLY $5.13
- ABEO $18.17
- AVG Volume (30 Days)
- HLLY 868.3K
- ABEO 659.6K
- Earning Date
- HLLY 08-06-2025
- ABEO 08-14-2025
- Dividend Yield
- HLLY N/A
- ABEO N/A
- EPS Growth
- HLLY N/A
- ABEO N/A
- EPS
- HLLY N/A
- ABEO 0.99
- Revenue
- HLLY $593,797,000.00
- ABEO $400,000.00
- Revenue This Year
- HLLY $0.38
- ABEO N/A
- Revenue Next Year
- HLLY $4.93
- ABEO $322.37
- P/E Ratio
- HLLY N/A
- ABEO $7.21
- Revenue Growth
- HLLY N/A
- ABEO N/A
- 52 Week Low
- HLLY $1.60
- ABEO $3.93
- 52 Week High
- HLLY $3.69
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- HLLY 78.68
- ABEO 66.56
- Support Level
- HLLY $1.98
- ABEO $6.21
- Resistance Level
- HLLY $3.68
- ABEO $6.94
- Average True Range (ATR)
- HLLY 0.18
- ABEO 0.30
- MACD
- HLLY 0.14
- ABEO 0.05
- Stochastic Oscillator
- HLLY 92.98
- ABEO 71.32
About HLLY Holley Inc.
Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.